老年心血管代谢性共病病人多重用药决策偏好的用户画像

打开文本图片集

Study on user persona of polypharmacy decision preferences among elderly patients with cardiometabolic multimorbidity

TANG Huizi， TAO Fuying，CHEN Lili，HOU Lili，TIAN Yingying

Women's HospitalofNanjingMedicalUniversity/NanjingWomenand Children's Healthcare Hospital，Jiangsu China

*Corresponding Author TIAN Yingying，E-mail：tianyingying@njmu.edu.cn

AbstractObjective：Toanalyzethetypesandcharacteristicsofdecisionpreferencesregardingpolypharmacyamong elderly patients withcardiometabolicultimorbidity（CMM），andprovideabasisforpersonalizedmedicationmanagementandinterventiostrategies. Methods：Basedonthecapabilityopportunitymotivation-behaviormodel（COM-B），a descriptivequalitativeresearchapproach was employed.Purposivesamplingasusedtorecruit18elderlypatientswithcardiometabolicmultimorbidityforemistructuredinteriews. Interviewdatawereanalyzedthroughcontentanalysis toextractandsummarizealabelingsystem，andavisualuserpersona was constructedacordinglyResults：Theuserpersoalabelsofedicationdecisionpreferencescoveredfourdimensions：basicharactetics capability，opporunityndotiationhprsonasereasifedintofourtys：participatiodisionakingtype，dedet exploration typ，dependentsupport tpeandpassive/resistanttype.Conclusions：Decisionpreferencesforpolyharmacyamongelderly CMMpatientsdemonstrateheterogeneityanddiversityMedicalstaffshouldformulatepersonalizedmedicationplansandmanagement strategies based on different preference types to improve patients'medication behavior.

Keywordscardiometabolicmultimorbidity；polypharmacy；decisionpreference;COM-Bmodel;userpersona;qualiativeresearch geriatric nursing

心血管代谢性共病（cardiometabolicmultimorbidity，CMM）是指病人同时存在2种及以上的心血管代谢性疾病[1]。（剩余8681字）